Depression during pregnancy: Detection, comorbidity and treatment

Asia-Pacific Psychiatry

Volumn 2, Issue 1, 2010, Pages 7-18

  Muzik, Maria ^a   Marcus, Sheila Marie ^a   Flynn, Heather ^a   Rosenblum, Katherine Lisa ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Comorbidity; Depression; Detection; Pregnancy; Treatment

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BRONCHODILATING AGENT; CARBAMAZEPINE; DECONGESTIVE AGENT; DOCOSAHEXAENOIC ACID; DULOXETINE; FLUOXETINE; FOLIC ACID; ICOSAPENTAENOIC ACID; IMMUNOSUPPRESSIVE AGENT; LAMOTRIGINE; LITHIUM CARBONATE; MIRTAZAPINE; MOOD STABILIZER; NEFAZODONE; NEUROLEPTIC AGENT; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; STEROID; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE;

ALCOHOLISM; ANENCEPHALUS; ANXIETY DISORDER; BECK DEPRESSION INVENTORY; BEHAVIOR THERAPY; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BLOOD CLOTTING DISORDER; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CIGARETTE SMOKING; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; CONGENITAL HEART DISEASE; CONGENITAL MALFORMATION; CRANIOFACIAL MALFORMATION; CRANIOFACIAL SYNOSTOSIS; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE PREDISPOSITION; EDINBURGH POSTNATAL DEPRESSION SCALE; ELECTROCONVULSIVE THERAPY; GROWTH RETARDATION; HUMAN; INFANTICIDE; INTESTINE OBSTRUCTION; IRRITABILITY; LANGUAGE ABILITY; MENTAL STRESS; MICROCEPHALY; MONOTHERAPY; MOTHER CHILD RELATION; MUSCLE HYPOTONIA; NERVOUSNESS; NEURAL TUBE DEFECT; OBSESSIVE COMPULSIVE DISORDER; OMPHALOCELE; PHOTOTHERAPY; POSTTRAUMATIC STRESS DISORDER; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL CARE; PRENATAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; PUERPERAL DEPRESSION; RESPIRATORY TRACT DISEASE; REVIEW; SCREENING; SEIZURE; SEXUAL ABUSE; SIDE EFFECT; SOCIAL SUPPORT; SPINA BIFIDA; SPONTANEOUS ABORTION; SUBSTANCE ABUSE; SUICIDE; TERATOGENICITY; URINE RETENTION; WEIGHT GAIN; WITHDRAWAL SYNDROME;

EID: 77953472723     PISSN: 17585864     EISSN: 17585872     Source Type: Journal    
DOI: 10.1111/j.1758-5872.2010.00051.x     Document Type: Review

References (57)

1. ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007) (2008) Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol. 111(4), 1001-20.
2. Alder J., et al. (2007) Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J Matern Fetal Neonatal Med. 20(3), 189-209.
3. Altshuler L.L., Hendrick V., Cohen L.S. (1998) Course of mood and anxiety disorders during pregnancy and the postpartum period. J Clin Psychiatry. 59(Suppl 2),29-33.
4. Alwan S., et al. (2007) Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med. 356(26), 2684-92.
5. Andrade S., et al. (2009) Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf. 18(3),246-252.
6. Beddoe A.E., Lee K.A. (2008) Mind-body interventions during pregnancy. J Obstet Gynecol Neonatal Nurs. 37(2), 165-75.
7. Bhatia S.C., Bhatia S.K. (1999) Depression in women: diagnostic and treatment considerations. Am Fam Physician. 60(1), 225-34, 239-40.
8. Bolton J.M., Robinson J., Sareen J. (2009) Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Affective Disorders. 115(3),367-75.
9. Chambers C.D., et al. (2006) Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 354(6), 579-87.
10. Chang G., et al. (1998) Alcohol use and pregnancy: improving identification. Obstet Gynecol. 91(6), 892-8.
11. Chudley A.E., et al. (2005) Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis. CMAJ. 172(suppl 5),S1-21.
12. Chun-Fai-Chan B., et al. (2005) Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol. 192(3), 932-6.
13. Cohen L.S., et al. (2006) Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. Jama. 295(5),499-507.
14. Cohen L.S. (2007) Treatment of bipolar disorder during pregnancy. J Clin Psychiatry. 68(Suppl 9), 4-9.
15. Cox J.L., Holden J.M., Sagovsky R. (1987) Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 150, 782-6.
16. Davis E., et al. (2007) Prenatal exposure to maternal depression and cortisol influences infant temperament. J Am Acad Child Adolesc Psychiatry. 46(6), 737-46.
17. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (2000) Washington, D.C.: American Psychiatric Association.
18. Dolk H., et al. (2008) Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations? Neurology. 71, 714-722.
19. Einarson A., et al. (2008) Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry. 165(6),749-52.
20. Einarson A. (2009) Risks/safety of psychotropic medication use during pregnancy-Motherisk Update 2008. Can J Clin Pharmacol. 16(1), 58-65.
21. Einarson A., et al. (2009) Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. J Obstet Gynaecol Can. 31(5), 452-6.
22. Einarson A., Selby P., Koren G. (2001) Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counseling. J Psychiatry Neurosci. 26(1), 44-8.
23. Feinman J.A., et al. (2000) Development of a model for the detection and treatment of depression in primary care. Psychiatr Q. 71(1), 59-78.
24. Ferreira E., et al. (2007) Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics. 119(1), 52-9.
25. Fisher J.B., et al. (1985) Neonatal apnea associated with maternal clonazepam therapy: a case report. Obstet Gynecol. 66(3 Suppl), 34S-35S.
26. Freeman M.P., et al. (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry. 67(12), 1954-67.
27. Gentile S. (2006) Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers. Bipolar Disord. 8(3), 207-20.
28. GlaxoSmithKline. (2005) http://www.gsk.com/media/ paroxetine/pregnancy- hcp-letter.pdf. [cited June 19, 2008].
29. Gonsalves L., Schuermeyer I. (2006) Treating depression in pregnancy: practical suggestions. Cleve Clin J Med. 73(12), 1098-104.
30. Hemels M.E., et al. (2005) Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann Pharmacother. 39(5), 803-9.
31. Holmes L.B., et al. (2001) The teratogenicity of anticonvulsant drugs. N Engl J Med. 344(15), 1132-8.
32. Kessler R.C., et al. (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 51(1), 8-19.
33. Koren G., et al. (2005) Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates? Cmaj. 172(11), 1457-9.
34. Lester B.M., Twomey J.E. (2008) Treatment of substance abuse during pregnancy.Womens Health (Lond Engl) Jan(4): 67-77.
35. Louik C., et al. (2007) First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med. 356(26), 2675-83.
36. Marcus S.M., et al. (2003) Depressive symptoms among pregnant women screened in obstetrics settings. JWomens Health (Larchmt). 12(4), 373-80.
37. McKenna K., et al. (2005) Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry. 66(4), 444-9; quiz 546.
38. Meyer C., Oberman M. (2001) MothersWho Kill Their Children: Inside theMinds of Moms From Susan Smith to the "PromMom.". New York: New York University Press.
39. Misri S., Kendrick K. (2007) Treatment of perinatal mood and anxiety disorders: a review. Can J Psychiatry. 52(8),489-98.
40. Morrow J.I., Craig J.J., Russell A.J.C. (2001) Epilepsy and pregnancy: a prospective register in the United Kingdom. J Neurol Sci. 187(suppl 1), S299.
41. Nulman I., et al. (1997) Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med. 336(4), 258-62.
42. O'Hara M.W., Neunaber D.J., Zekoski E.M. (1984) Prospective study of postpartum depression: prevalence, course, and predictive factors. J Abnorm Psychol. 93(2),158-71.
43. Parker B., McFarlane J., Soeken K. (1994) Abuse during pregnancy: effects on maternal complications and birth weight in adult and teenage women. Obstet Gynecol. 84(3), 323-8.
44. Rabheru K. (2001) The use of electroconvulsive therapy in special patient populations. Canadian Journal of Psychiatry. 46(October), 710-719.
45. Radloff L. (1977) The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement. 1, 385-401.
46. Resnick H.S., et al. (1993) Prevalence of civilian trauma and posttraumatic stress disorder in a representative national sample of women. J Consult Clin Psychol. 61(6), 984-91.
47. Robinson J., et al. (2009) Self-medication of anxiety disorders with alcohol and drugs: results from a nationally representative sample. Journal of Anxiety Disorders. 23(1), 38-45.
48. Roeloffs C., et al. (2003) Stigma and depression among primary care patients. General Hospital Psychiatry. 25(5), 311-315.
49. Ross A.S., et al. (2006) Antenatal & neonatal guidelines, education & learning system. J Ark Med Soc. 102(12),328-30.
50. Sharma V. (2006) A cautionary note on the use of antidepressants in postpartum depression. Bipolar Disord. 8(4), 411-4.
51. Sharma V. (2009) Management of Bipolar II Disorder during Pregnancy and the Postpartum Period. Can J Clin Pharmacol. 16(1), 33-41.
52. Viguera A.C., et al. (2000) Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry. 157(1), 179-84.
53. Weissman M.M., Olfson M. (1995) Depression in women: implications for health care research. Science. 269(5225), 799-801.
54. Westdahl C., et al. (2007) Social support and social conflict as predictors of prenatal depression. Obstet Gynecol. 110(1), 134-40.
55. Wichman C., et al. (2009) Congenital Heart Disease Associated With Selective Serotonin Reuptake Inhibitor Use During Pregnancy. Mayo Clin Proc. 84(1),23-27.
56. Widom C.S., Czaja S.J., Dutton M.A. (2008) Childhood victimization and lifetime revictimization. Child Abuse and Neglect. 32(8), 785-796.
57. Yonkers K.A., et al. (2009) The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. General Hospital Psychiatry. 31(5), 403-413.